Mental Health Clinics in Sturtevant, WI Accepting Medicare
1 Mental Health Clinics found. Showing 1 - 1
 Psychiatric Services Of Racine, Llp Psychologist - Prescribing (Medical) Medicare: Medicare Enrolled Practice Location: 8700 Durand Ave Ste 600, Sturtevant, WI 53177 Phone: 262-635-5520 Fax: 262-635-5530 |
News Archive
Viewpoints: Sen. Hatch's prescription for safeguarding entitlements; Medicare crackdown on CVS drug program; JFK's mental health vision failing
American families are used to working with dollar amounts starting with hundreds and thousands. But the fiscal situation of our country requires us to act in terms of billions and trillions. ... Unfortunately, waiting until the last minute to stop a crisis has become standard operating procedure in Washington. But that isn't how we should be tackling our debt or safeguarding Medicare and Medicaid.
Study of latest in clinical data technology applied to Phase II clinical trial in South Africa
Last week, at the fourth annual Clinical Trials in Emerging Economies conference, Margaret Ann Snowden, Director of Biostatistics and Data Management at Aeras Global TB Vaccine Foundation, and Daragh Ryan of Cmed Technology, presented a case study of the application of the latest in clinical data technology to a large Phase II clinical trial in South Africa. The presentation provided an update on how effective technology can be in promoting the development of affordable vaccine regimens for the prevention of tuberculosis (TB) worldwide.
Commercial ultrasonic frequency devices are not effective in repelling insects
Alternative means of controlling urban insect pests by using ultrasonic frequencies are available and marketed to the public. However, few of these devices have been demonstrated as being effective in repelling insect pests such as mosquitoes, cockroaches, or ants. Despite the lack of evidence for the efficacy of such devices, they continue to be sold and new versions targeting bed bugs are readily available.
UMDNJ, Proteonomix to conduct UMK-121 Phase 1 trial in end-stage liver disease
Proteonomix, Inc., a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, today announced it has entered into an agreement with Piscataway, N.J.-based University of Medicine and Dentistry of New Jersey (UMDNJ) to conducted a Phase 1 clinical trial with its proprietary, patent-pending mobilization technology UMK-121 in patients with end-stage liver disease (ESLD).
› Verified 8 days ago